Executive Director, Asset Strategy Leadership

Role: Executive Director, Asset Strategy Leadership, focusing on strategic positioning of small molecule clinical programs in oncology and immunology/inflammation. Responsibilities: define and drive asset strategies, leverage AI and proprietary data to differentiate assets, develop competitive narratives, and align resource allocation across clinical, discovery, and platform teams. Requirements: PhD in life sciences or related field; 10+ years in biotech/pharma with asset-level strategic leadership, specializing in small molecule therapeutics for oncology and immunology; experience with computational approaches in drug development; strong strategic, scientific, and financial acumen; exceptional communication skills. HighValue: oncology and immunology/inflammation, clinical stage programs, AI-enabled platform, cross-functional collaboration, leadership in a high-tech biotech environment, hybrid role based in New York City. WorkSetup: hybrid NYC; no travel specified.